ARCHIVES

New Therapies Could Benefit Patients With Difficult Cancers

This article is from The Cancer Letter archive.

Vol. 33 No. 6 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

Consensus Conference On Localized Prostate Cancer June 15-17

November 21, 1986

NCI Extramural Program: Advisors Approve Concepts For Diagnostic Imaging Trials Group

March 21, 1997

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

NCA Approves New Guidelines For Comprehensive Review

December 8, 1989

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975